Medical Care
Global In Vitro Transcription Solutions Market Research Report 2025
- May 12, 25
- ID: 235422
- Pages: 76
- Figures: 76
- Views: 9
The global market for In Vitro Transcription Solutions was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
In vitro transcription requires a purified linear DNA template containing a promoter, ribonucleotide triphosphates, a buffer system that includes DTT and magnesium ions, and an appropriate phage RNA polymerase. The exact conditions used in the transcription reaction depend on the amount of RNA needed for a specific application.
North American market for In Vitro Transcription Solutions is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for In Vitro Transcription Solutions is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for In Vitro Transcription Solutions in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of In Vitro Transcription Solutions include Thermo Fisher Scientific, Inc., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Takara Bio Inc., Lucigen Corporation, Enzynomics Co. Ltd., Enzo Life Sciences, Inc., Cytiva (Danaher), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for In Vitro Transcription Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Transcription Solutions.
The In Vitro Transcription Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vitro Transcription Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Transcription Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific, Inc.
Promega Corporation
Agilent Technologies, Inc.
New England Biolabs
Takara Bio Inc.
Lucigen Corporation
Enzynomics Co. Ltd.
Enzo Life Sciences, Inc.
Cytiva (Danaher)
Segment by Type
Cancer
Infectious Diseases
Lifestyle Diseases
Genetic Diseases
Others
Segment by Application
Pharmaceutical & Biotechnology Companies
CROs & CMOs
Academics & Research
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Transcription Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In vitro transcription requires a purified linear DNA template containing a promoter, ribonucleotide triphosphates, a buffer system that includes DTT and magnesium ions, and an appropriate phage RNA polymerase. The exact conditions used in the transcription reaction depend on the amount of RNA needed for a specific application.
North American market for In Vitro Transcription Solutions is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for In Vitro Transcription Solutions is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for In Vitro Transcription Solutions in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of In Vitro Transcription Solutions include Thermo Fisher Scientific, Inc., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Takara Bio Inc., Lucigen Corporation, Enzynomics Co. Ltd., Enzo Life Sciences, Inc., Cytiva (Danaher), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for In Vitro Transcription Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Transcription Solutions.
The In Vitro Transcription Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vitro Transcription Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Transcription Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific, Inc.
Promega Corporation
Agilent Technologies, Inc.
New England Biolabs
Takara Bio Inc.
Lucigen Corporation
Enzynomics Co. Ltd.
Enzo Life Sciences, Inc.
Cytiva (Danaher)
Segment by Type
Cancer
Infectious Diseases
Lifestyle Diseases
Genetic Diseases
Others
Segment by Application
Pharmaceutical & Biotechnology Companies
CROs & CMOs
Academics & Research
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Transcription Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Transcription Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cancer
1.2.3 Infectious Diseases
1.2.4 Lifestyle Diseases
1.2.5 Genetic Diseases
1.2.6 Others
1.3 Market by Application
1.3.1 Global In Vitro Transcription Solutions Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 CROs & CMOs
1.3.4 Academics & Research
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Transcription Solutions Market Perspective (2020-2031)
2.2 Global In Vitro Transcription Solutions Growth Trends by Region
2.2.1 Global In Vitro Transcription Solutions Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In Vitro Transcription Solutions Historic Market Size by Region (2020-2025)
2.2.3 In Vitro Transcription Solutions Forecasted Market Size by Region (2026-2031)
2.3 In Vitro Transcription Solutions Market Dynamics
2.3.1 In Vitro Transcription Solutions Industry Trends
2.3.2 In Vitro Transcription Solutions Market Drivers
2.3.3 In Vitro Transcription Solutions Market Challenges
2.3.4 In Vitro Transcription Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Transcription Solutions Players by Revenue
3.1.1 Global Top In Vitro Transcription Solutions Players by Revenue (2020-2025)
3.1.2 Global In Vitro Transcription Solutions Revenue Market Share by Players (2020-2025)
3.2 Global In Vitro Transcription Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In Vitro Transcription Solutions Revenue
3.4 Global In Vitro Transcription Solutions Market Concentration Ratio
3.4.1 Global In Vitro Transcription Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Transcription Solutions Revenue in 2024
3.5 Global Key Players of In Vitro Transcription Solutions Head office and Area Served
3.6 Global Key Players of In Vitro Transcription Solutions, Product and Application
3.7 Global Key Players of In Vitro Transcription Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Transcription Solutions Breakdown Data by Type
4.1 Global In Vitro Transcription Solutions Historic Market Size by Type (2020-2025)
4.2 Global In Vitro Transcription Solutions Forecasted Market Size by Type (2026-2031)
5 In Vitro Transcription Solutions Breakdown Data by Application
5.1 Global In Vitro Transcription Solutions Historic Market Size by Application (2020-2025)
5.2 Global In Vitro Transcription Solutions Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In Vitro Transcription Solutions Market Size (2020-2031)
6.2 North America In Vitro Transcription Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In Vitro Transcription Solutions Market Size by Country (2020-2025)
6.4 North America In Vitro Transcription Solutions Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Transcription Solutions Market Size (2020-2031)
7.2 Europe In Vitro Transcription Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In Vitro Transcription Solutions Market Size by Country (2020-2025)
7.4 Europe In Vitro Transcription Solutions Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Transcription Solutions Market Size (2020-2031)
8.2 Asia-Pacific In Vitro Transcription Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In Vitro Transcription Solutions Market Size by Region (2020-2025)
8.4 Asia-Pacific In Vitro Transcription Solutions Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Transcription Solutions Market Size (2020-2031)
9.2 Latin America In Vitro Transcription Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In Vitro Transcription Solutions Market Size by Country (2020-2025)
9.4 Latin America In Vitro Transcription Solutions Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Transcription Solutions Market Size (2020-2031)
10.2 Middle East & Africa In Vitro Transcription Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In Vitro Transcription Solutions Market Size by Country (2020-2025)
10.4 Middle East & Africa In Vitro Transcription Solutions Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Details
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. In Vitro Transcription Solutions Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 Promega Corporation
11.2.1 Promega Corporation Company Details
11.2.2 Promega Corporation Business Overview
11.2.3 Promega Corporation In Vitro Transcription Solutions Introduction
11.2.4 Promega Corporation Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.2.5 Promega Corporation Recent Development
11.3 Agilent Technologies, Inc.
11.3.1 Agilent Technologies, Inc. Company Details
11.3.2 Agilent Technologies, Inc. Business Overview
11.3.3 Agilent Technologies, Inc. In Vitro Transcription Solutions Introduction
11.3.4 Agilent Technologies, Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.3.5 Agilent Technologies, Inc. Recent Development
11.4 New England Biolabs
11.4.1 New England Biolabs Company Details
11.4.2 New England Biolabs Business Overview
11.4.3 New England Biolabs In Vitro Transcription Solutions Introduction
11.4.4 New England Biolabs Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.4.5 New England Biolabs Recent Development
11.5 Takara Bio Inc.
11.5.1 Takara Bio Inc. Company Details
11.5.2 Takara Bio Inc. Business Overview
11.5.3 Takara Bio Inc. In Vitro Transcription Solutions Introduction
11.5.4 Takara Bio Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.5.5 Takara Bio Inc. Recent Development
11.6 Lucigen Corporation
11.6.1 Lucigen Corporation Company Details
11.6.2 Lucigen Corporation Business Overview
11.6.3 Lucigen Corporation In Vitro Transcription Solutions Introduction
11.6.4 Lucigen Corporation Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.6.5 Lucigen Corporation Recent Development
11.7 Enzynomics Co. Ltd.
11.7.1 Enzynomics Co. Ltd. Company Details
11.7.2 Enzynomics Co. Ltd. Business Overview
11.7.3 Enzynomics Co. Ltd. In Vitro Transcription Solutions Introduction
11.7.4 Enzynomics Co. Ltd. Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.7.5 Enzynomics Co. Ltd. Recent Development
11.8 Enzo Life Sciences, Inc.
11.8.1 Enzo Life Sciences, Inc. Company Details
11.8.2 Enzo Life Sciences, Inc. Business Overview
11.8.3 Enzo Life Sciences, Inc. In Vitro Transcription Solutions Introduction
11.8.4 Enzo Life Sciences, Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.8.5 Enzo Life Sciences, Inc. Recent Development
11.9 Cytiva (Danaher)
11.9.1 Cytiva (Danaher) Company Details
11.9.2 Cytiva (Danaher) Business Overview
11.9.3 Cytiva (Danaher) In Vitro Transcription Solutions Introduction
11.9.4 Cytiva (Danaher) Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.9.5 Cytiva (Danaher) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Transcription Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cancer
1.2.3 Infectious Diseases
1.2.4 Lifestyle Diseases
1.2.5 Genetic Diseases
1.2.6 Others
1.3 Market by Application
1.3.1 Global In Vitro Transcription Solutions Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 CROs & CMOs
1.3.4 Academics & Research
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Transcription Solutions Market Perspective (2020-2031)
2.2 Global In Vitro Transcription Solutions Growth Trends by Region
2.2.1 Global In Vitro Transcription Solutions Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In Vitro Transcription Solutions Historic Market Size by Region (2020-2025)
2.2.3 In Vitro Transcription Solutions Forecasted Market Size by Region (2026-2031)
2.3 In Vitro Transcription Solutions Market Dynamics
2.3.1 In Vitro Transcription Solutions Industry Trends
2.3.2 In Vitro Transcription Solutions Market Drivers
2.3.3 In Vitro Transcription Solutions Market Challenges
2.3.4 In Vitro Transcription Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Transcription Solutions Players by Revenue
3.1.1 Global Top In Vitro Transcription Solutions Players by Revenue (2020-2025)
3.1.2 Global In Vitro Transcription Solutions Revenue Market Share by Players (2020-2025)
3.2 Global In Vitro Transcription Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In Vitro Transcription Solutions Revenue
3.4 Global In Vitro Transcription Solutions Market Concentration Ratio
3.4.1 Global In Vitro Transcription Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Transcription Solutions Revenue in 2024
3.5 Global Key Players of In Vitro Transcription Solutions Head office and Area Served
3.6 Global Key Players of In Vitro Transcription Solutions, Product and Application
3.7 Global Key Players of In Vitro Transcription Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Transcription Solutions Breakdown Data by Type
4.1 Global In Vitro Transcription Solutions Historic Market Size by Type (2020-2025)
4.2 Global In Vitro Transcription Solutions Forecasted Market Size by Type (2026-2031)
5 In Vitro Transcription Solutions Breakdown Data by Application
5.1 Global In Vitro Transcription Solutions Historic Market Size by Application (2020-2025)
5.2 Global In Vitro Transcription Solutions Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In Vitro Transcription Solutions Market Size (2020-2031)
6.2 North America In Vitro Transcription Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In Vitro Transcription Solutions Market Size by Country (2020-2025)
6.4 North America In Vitro Transcription Solutions Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Transcription Solutions Market Size (2020-2031)
7.2 Europe In Vitro Transcription Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In Vitro Transcription Solutions Market Size by Country (2020-2025)
7.4 Europe In Vitro Transcription Solutions Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Transcription Solutions Market Size (2020-2031)
8.2 Asia-Pacific In Vitro Transcription Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In Vitro Transcription Solutions Market Size by Region (2020-2025)
8.4 Asia-Pacific In Vitro Transcription Solutions Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Transcription Solutions Market Size (2020-2031)
9.2 Latin America In Vitro Transcription Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In Vitro Transcription Solutions Market Size by Country (2020-2025)
9.4 Latin America In Vitro Transcription Solutions Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Transcription Solutions Market Size (2020-2031)
10.2 Middle East & Africa In Vitro Transcription Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In Vitro Transcription Solutions Market Size by Country (2020-2025)
10.4 Middle East & Africa In Vitro Transcription Solutions Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Details
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. In Vitro Transcription Solutions Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 Promega Corporation
11.2.1 Promega Corporation Company Details
11.2.2 Promega Corporation Business Overview
11.2.3 Promega Corporation In Vitro Transcription Solutions Introduction
11.2.4 Promega Corporation Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.2.5 Promega Corporation Recent Development
11.3 Agilent Technologies, Inc.
11.3.1 Agilent Technologies, Inc. Company Details
11.3.2 Agilent Technologies, Inc. Business Overview
11.3.3 Agilent Technologies, Inc. In Vitro Transcription Solutions Introduction
11.3.4 Agilent Technologies, Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.3.5 Agilent Technologies, Inc. Recent Development
11.4 New England Biolabs
11.4.1 New England Biolabs Company Details
11.4.2 New England Biolabs Business Overview
11.4.3 New England Biolabs In Vitro Transcription Solutions Introduction
11.4.4 New England Biolabs Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.4.5 New England Biolabs Recent Development
11.5 Takara Bio Inc.
11.5.1 Takara Bio Inc. Company Details
11.5.2 Takara Bio Inc. Business Overview
11.5.3 Takara Bio Inc. In Vitro Transcription Solutions Introduction
11.5.4 Takara Bio Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.5.5 Takara Bio Inc. Recent Development
11.6 Lucigen Corporation
11.6.1 Lucigen Corporation Company Details
11.6.2 Lucigen Corporation Business Overview
11.6.3 Lucigen Corporation In Vitro Transcription Solutions Introduction
11.6.4 Lucigen Corporation Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.6.5 Lucigen Corporation Recent Development
11.7 Enzynomics Co. Ltd.
11.7.1 Enzynomics Co. Ltd. Company Details
11.7.2 Enzynomics Co. Ltd. Business Overview
11.7.3 Enzynomics Co. Ltd. In Vitro Transcription Solutions Introduction
11.7.4 Enzynomics Co. Ltd. Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.7.5 Enzynomics Co. Ltd. Recent Development
11.8 Enzo Life Sciences, Inc.
11.8.1 Enzo Life Sciences, Inc. Company Details
11.8.2 Enzo Life Sciences, Inc. Business Overview
11.8.3 Enzo Life Sciences, Inc. In Vitro Transcription Solutions Introduction
11.8.4 Enzo Life Sciences, Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.8.5 Enzo Life Sciences, Inc. Recent Development
11.9 Cytiva (Danaher)
11.9.1 Cytiva (Danaher) Company Details
11.9.2 Cytiva (Danaher) Business Overview
11.9.3 Cytiva (Danaher) In Vitro Transcription Solutions Introduction
11.9.4 Cytiva (Danaher) Revenue in In Vitro Transcription Solutions Business (2020-2025)
11.9.5 Cytiva (Danaher) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global In Vitro Transcription Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cancer
Table 3. Key Players of Infectious Diseases
Table 4. Key Players of Lifestyle Diseases
Table 5. Key Players of Genetic Diseases
Table 6. Key Players of Others
Table 7. Global In Vitro Transcription Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global In Vitro Transcription Solutions Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global In Vitro Transcription Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global In Vitro Transcription Solutions Market Share by Region (2020-2025)
Table 11. Global In Vitro Transcription Solutions Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global In Vitro Transcription Solutions Market Share by Region (2026-2031)
Table 13. In Vitro Transcription Solutions Market Trends
Table 14. In Vitro Transcription Solutions Market Drivers
Table 15. In Vitro Transcription Solutions Market Challenges
Table 16. In Vitro Transcription Solutions Market Restraints
Table 17. Global In Vitro Transcription Solutions Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global In Vitro Transcription Solutions Market Share by Players (2020-2025)
Table 19. Global Top In Vitro Transcription Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Transcription Solutions as of 2024)
Table 20. Ranking of Global Top In Vitro Transcription Solutions Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by In Vitro Transcription Solutions Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of In Vitro Transcription Solutions, Headquarters and Area Served
Table 23. Global Key Players of In Vitro Transcription Solutions, Product and Application
Table 24. Global Key Players of In Vitro Transcription Solutions, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global In Vitro Transcription Solutions Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global In Vitro Transcription Solutions Revenue Market Share by Type (2020-2025)
Table 28. Global In Vitro Transcription Solutions Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global In Vitro Transcription Solutions Revenue Market Share by Type (2026-2031)
Table 30. Global In Vitro Transcription Solutions Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global In Vitro Transcription Solutions Revenue Market Share by Application (2020-2025)
Table 32. Global In Vitro Transcription Solutions Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global In Vitro Transcription Solutions Revenue Market Share by Application (2026-2031)
Table 34. North America In Vitro Transcription Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America In Vitro Transcription Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America In Vitro Transcription Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe In Vitro Transcription Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe In Vitro Transcription Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe In Vitro Transcription Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific In Vitro Transcription Solutions Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific In Vitro Transcription Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific In Vitro Transcription Solutions Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America In Vitro Transcription Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America In Vitro Transcription Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America In Vitro Transcription Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa In Vitro Transcription Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa In Vitro Transcription Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa In Vitro Transcription Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 49. Thermo Fisher Scientific, Inc. Company Details
Table 50. Thermo Fisher Scientific, Inc. Business Overview
Table 51. Thermo Fisher Scientific, Inc. In Vitro Transcription Solutions Product
Table 52. Thermo Fisher Scientific, Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 53. Thermo Fisher Scientific, Inc. Recent Development
Table 54. Promega Corporation Company Details
Table 55. Promega Corporation Business Overview
Table 56. Promega Corporation In Vitro Transcription Solutions Product
Table 57. Promega Corporation Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 58. Promega Corporation Recent Development
Table 59. Agilent Technologies, Inc. Company Details
Table 60. Agilent Technologies, Inc. Business Overview
Table 61. Agilent Technologies, Inc. In Vitro Transcription Solutions Product
Table 62. Agilent Technologies, Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 63. Agilent Technologies, Inc. Recent Development
Table 64. New England Biolabs Company Details
Table 65. New England Biolabs Business Overview
Table 66. New England Biolabs In Vitro Transcription Solutions Product
Table 67. New England Biolabs Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 68. New England Biolabs Recent Development
Table 69. Takara Bio Inc. Company Details
Table 70. Takara Bio Inc. Business Overview
Table 71. Takara Bio Inc. In Vitro Transcription Solutions Product
Table 72. Takara Bio Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 73. Takara Bio Inc. Recent Development
Table 74. Lucigen Corporation Company Details
Table 75. Lucigen Corporation Business Overview
Table 76. Lucigen Corporation In Vitro Transcription Solutions Product
Table 77. Lucigen Corporation Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 78. Lucigen Corporation Recent Development
Table 79. Enzynomics Co. Ltd. Company Details
Table 80. Enzynomics Co. Ltd. Business Overview
Table 81. Enzynomics Co. Ltd. In Vitro Transcription Solutions Product
Table 82. Enzynomics Co. Ltd. Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 83. Enzynomics Co. Ltd. Recent Development
Table 84. Enzo Life Sciences, Inc. Company Details
Table 85. Enzo Life Sciences, Inc. Business Overview
Table 86. Enzo Life Sciences, Inc. In Vitro Transcription Solutions Product
Table 87. Enzo Life Sciences, Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 88. Enzo Life Sciences, Inc. Recent Development
Table 89. Cytiva (Danaher) Company Details
Table 90. Cytiva (Danaher) Business Overview
Table 91. Cytiva (Danaher) In Vitro Transcription Solutions Product
Table 92. Cytiva (Danaher) Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 93. Cytiva (Danaher) Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. In Vitro Transcription Solutions Picture
Figure 2. Global In Vitro Transcription Solutions Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global In Vitro Transcription Solutions Market Share by Type: 2024 VS 2031
Figure 4. Cancer Features
Figure 5. Infectious Diseases Features
Figure 6. Lifestyle Diseases Features
Figure 7. Genetic Diseases Features
Figure 8. Others Features
Figure 9. Global In Vitro Transcription Solutions Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global In Vitro Transcription Solutions Market Share by Application: 2024 VS 2031
Figure 11. Pharmaceutical & Biotechnology Companies Case Studies
Figure 12. CROs & CMOs Case Studies
Figure 13. Academics & Research Case Studies
Figure 14. Others Case Studies
Figure 15. In Vitro Transcription Solutions Report Years Considered
Figure 16. Global In Vitro Transcription Solutions Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global In Vitro Transcription Solutions Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global In Vitro Transcription Solutions Market Share by Region: 2024 VS 2031
Figure 19. Global In Vitro Transcription Solutions Market Share by Players in 2024
Figure 20. Global Top In Vitro Transcription Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Transcription Solutions as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by In Vitro Transcription Solutions Revenue in 2024
Figure 22. North America In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America In Vitro Transcription Solutions Market Share by Country (2020-2031)
Figure 24. United States In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe In Vitro Transcription Solutions Market Share by Country (2020-2031)
Figure 28. Germany In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific In Vitro Transcription Solutions Market Share by Region (2020-2031)
Figure 36. China In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America In Vitro Transcription Solutions Market Share by Country (2020-2031)
Figure 44. Mexico In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa In Vitro Transcription Solutions Market Share by Country (2020-2031)
Figure 48. Turkey In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Thermo Fisher Scientific, Inc. Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 52. Promega Corporation Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 53. Agilent Technologies, Inc. Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 54. New England Biolabs Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 55. Takara Bio Inc. Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 56. Lucigen Corporation Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 57. Enzynomics Co. Ltd. Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 58. Enzo Life Sciences, Inc. Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 59. Cytiva (Danaher) Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global In Vitro Transcription Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cancer
Table 3. Key Players of Infectious Diseases
Table 4. Key Players of Lifestyle Diseases
Table 5. Key Players of Genetic Diseases
Table 6. Key Players of Others
Table 7. Global In Vitro Transcription Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global In Vitro Transcription Solutions Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global In Vitro Transcription Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global In Vitro Transcription Solutions Market Share by Region (2020-2025)
Table 11. Global In Vitro Transcription Solutions Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global In Vitro Transcription Solutions Market Share by Region (2026-2031)
Table 13. In Vitro Transcription Solutions Market Trends
Table 14. In Vitro Transcription Solutions Market Drivers
Table 15. In Vitro Transcription Solutions Market Challenges
Table 16. In Vitro Transcription Solutions Market Restraints
Table 17. Global In Vitro Transcription Solutions Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global In Vitro Transcription Solutions Market Share by Players (2020-2025)
Table 19. Global Top In Vitro Transcription Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Transcription Solutions as of 2024)
Table 20. Ranking of Global Top In Vitro Transcription Solutions Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by In Vitro Transcription Solutions Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of In Vitro Transcription Solutions, Headquarters and Area Served
Table 23. Global Key Players of In Vitro Transcription Solutions, Product and Application
Table 24. Global Key Players of In Vitro Transcription Solutions, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global In Vitro Transcription Solutions Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global In Vitro Transcription Solutions Revenue Market Share by Type (2020-2025)
Table 28. Global In Vitro Transcription Solutions Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global In Vitro Transcription Solutions Revenue Market Share by Type (2026-2031)
Table 30. Global In Vitro Transcription Solutions Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global In Vitro Transcription Solutions Revenue Market Share by Application (2020-2025)
Table 32. Global In Vitro Transcription Solutions Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global In Vitro Transcription Solutions Revenue Market Share by Application (2026-2031)
Table 34. North America In Vitro Transcription Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America In Vitro Transcription Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America In Vitro Transcription Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe In Vitro Transcription Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe In Vitro Transcription Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe In Vitro Transcription Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific In Vitro Transcription Solutions Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific In Vitro Transcription Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific In Vitro Transcription Solutions Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America In Vitro Transcription Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America In Vitro Transcription Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America In Vitro Transcription Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa In Vitro Transcription Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa In Vitro Transcription Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa In Vitro Transcription Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 49. Thermo Fisher Scientific, Inc. Company Details
Table 50. Thermo Fisher Scientific, Inc. Business Overview
Table 51. Thermo Fisher Scientific, Inc. In Vitro Transcription Solutions Product
Table 52. Thermo Fisher Scientific, Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 53. Thermo Fisher Scientific, Inc. Recent Development
Table 54. Promega Corporation Company Details
Table 55. Promega Corporation Business Overview
Table 56. Promega Corporation In Vitro Transcription Solutions Product
Table 57. Promega Corporation Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 58. Promega Corporation Recent Development
Table 59. Agilent Technologies, Inc. Company Details
Table 60. Agilent Technologies, Inc. Business Overview
Table 61. Agilent Technologies, Inc. In Vitro Transcription Solutions Product
Table 62. Agilent Technologies, Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 63. Agilent Technologies, Inc. Recent Development
Table 64. New England Biolabs Company Details
Table 65. New England Biolabs Business Overview
Table 66. New England Biolabs In Vitro Transcription Solutions Product
Table 67. New England Biolabs Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 68. New England Biolabs Recent Development
Table 69. Takara Bio Inc. Company Details
Table 70. Takara Bio Inc. Business Overview
Table 71. Takara Bio Inc. In Vitro Transcription Solutions Product
Table 72. Takara Bio Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 73. Takara Bio Inc. Recent Development
Table 74. Lucigen Corporation Company Details
Table 75. Lucigen Corporation Business Overview
Table 76. Lucigen Corporation In Vitro Transcription Solutions Product
Table 77. Lucigen Corporation Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 78. Lucigen Corporation Recent Development
Table 79. Enzynomics Co. Ltd. Company Details
Table 80. Enzynomics Co. Ltd. Business Overview
Table 81. Enzynomics Co. Ltd. In Vitro Transcription Solutions Product
Table 82. Enzynomics Co. Ltd. Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 83. Enzynomics Co. Ltd. Recent Development
Table 84. Enzo Life Sciences, Inc. Company Details
Table 85. Enzo Life Sciences, Inc. Business Overview
Table 86. Enzo Life Sciences, Inc. In Vitro Transcription Solutions Product
Table 87. Enzo Life Sciences, Inc. Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 88. Enzo Life Sciences, Inc. Recent Development
Table 89. Cytiva (Danaher) Company Details
Table 90. Cytiva (Danaher) Business Overview
Table 91. Cytiva (Danaher) In Vitro Transcription Solutions Product
Table 92. Cytiva (Danaher) Revenue in In Vitro Transcription Solutions Business (2020-2025) & (US$ Million)
Table 93. Cytiva (Danaher) Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. In Vitro Transcription Solutions Picture
Figure 2. Global In Vitro Transcription Solutions Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global In Vitro Transcription Solutions Market Share by Type: 2024 VS 2031
Figure 4. Cancer Features
Figure 5. Infectious Diseases Features
Figure 6. Lifestyle Diseases Features
Figure 7. Genetic Diseases Features
Figure 8. Others Features
Figure 9. Global In Vitro Transcription Solutions Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global In Vitro Transcription Solutions Market Share by Application: 2024 VS 2031
Figure 11. Pharmaceutical & Biotechnology Companies Case Studies
Figure 12. CROs & CMOs Case Studies
Figure 13. Academics & Research Case Studies
Figure 14. Others Case Studies
Figure 15. In Vitro Transcription Solutions Report Years Considered
Figure 16. Global In Vitro Transcription Solutions Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global In Vitro Transcription Solutions Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global In Vitro Transcription Solutions Market Share by Region: 2024 VS 2031
Figure 19. Global In Vitro Transcription Solutions Market Share by Players in 2024
Figure 20. Global Top In Vitro Transcription Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Transcription Solutions as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by In Vitro Transcription Solutions Revenue in 2024
Figure 22. North America In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America In Vitro Transcription Solutions Market Share by Country (2020-2031)
Figure 24. United States In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe In Vitro Transcription Solutions Market Share by Country (2020-2031)
Figure 28. Germany In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific In Vitro Transcription Solutions Market Share by Region (2020-2031)
Figure 36. China In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America In Vitro Transcription Solutions Market Share by Country (2020-2031)
Figure 44. Mexico In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa In Vitro Transcription Solutions Market Share by Country (2020-2031)
Figure 48. Turkey In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE In Vitro Transcription Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Thermo Fisher Scientific, Inc. Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 52. Promega Corporation Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 53. Agilent Technologies, Inc. Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 54. New England Biolabs Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 55. Takara Bio Inc. Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 56. Lucigen Corporation Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 57. Enzynomics Co. Ltd. Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 58. Enzo Life Sciences, Inc. Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 59. Cytiva (Danaher) Revenue Growth Rate in In Vitro Transcription Solutions Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232